SCHEMBL22155484

SCHEMBL22155484

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4c4cc6c7ccccc7n(-c7ccccc7)c6cc54)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
KMT2A Q03164 2/20 0.36
IL1R1 P14778 1/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
PTGER4 P35408 1/20 0.33
MAPK14 Q16539 1/20 0.32
TSPO P30536 1/20 0.32
HDAC4 P56524 1/20 0.32
HSD17B10 Q99714 1/20 0.31
EDNRA P25101 2/20 0.30
MAPK1 P28482 1/20 0.30
EDNRB P24530 1/20 0.30
NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14461153 0.92 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL22155595 0.91 L3MBTL1 (0.51) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL14728149 0.91 L3MBTL1 (0.51) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL14728147 0.91 L3MBTL1 (0.51) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL19103090 0.90 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL16263486 0.88 L3MBTL1 (0.51) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL22707012 0.87 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL22155132 0.87 KDM4E (0.42) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL13057858 0.87 L3MBTL1 (0.60) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL22707030 0.86 L3MBTL1 (0.49) L3MBTL1KDM4EATMKMT2AIL1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 L3MBTL1 410/4885KDM4E 2771/4885ATM 4295/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 L3MBTL1 410/4885KDM4E 2771/4885ATM 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.